Aug 4, 2026 04:05PM
Jul 30, 2026 05:57PM
Jul 20, 2026 09:05AM
Jul 20, 2026 09:05AM
Jul 15, 2026 04:05PM
Jul 6, 2026 09:04AM
Jun 26, 2026 06:49AM EU panel backs Acadia's Rett syndrome drug trofinetide for approval
Jun 26, 2026 06:49AM
May 6, 2026 04:05PM
Apr 30, 2026 04:05PM
Apr 28, 2026 04:05PM
Apr 17, 2026 09:05AM
Apr 15, 2026 04:05PM
Apr 7, 2026 09:08AM ACADIA Pharmaceuticals launches powder formulation of Rett syndrome drug
Apr 7, 2026 09:05AM
Mar 12, 2026 04:05PM
Mar 3, 2026 04:05PM
Mar 3, 2026 04:05PM
Mar 2, 2026 04:56PM
Mar 2, 2026 04:05PM
Mar 2, 2026 04:05PM Acadia Pharmaceuticals Announces Plan to Request Re-Examination Following Negative CHMP Opinion for Trofinetide for the Treatment of Rett Syndrome
Feb 25, 2026 04:05PM
Feb 23, 2026 04:05PM
Feb 4, 2026 04:05PM
Feb 3, 2026 06:36AM
Feb 2, 2026 04:14PM
Feb 2, 2026 04:05PM
Jan 13, 2026 09:02AM ACADIA projects $1.7 billion in 2028 sales, launches new DAYBUE formulation
Jan 13, 2026 09:00AM
Dec 18, 2025 04:05PM
Dec 12, 2025 08:00AM
Dec 12, 2025 08:00AM
Nov 20, 2025 04:05PM
Nov 16, 2025 03:00PM
Nov 5, 2025 04:05PM Acadia Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operating Overview
Oct 28, 2025 04:05PM
Oct 15, 2025 04:05PM
Oct 2, 2025 09:05AM
Oct 2, 2025 09:04AM
Sep 24, 2025 07:00AM
Sep 24, 2025 07:00AM
Sep 12, 2025 04:05PM ACADIA publishes real-world data on DAYBUE for Rett syndrome treatment
Sep 12, 2025 04:05PM
Sep 11, 2025 08:18AM
Sep 8, 2025 04:05PM
Aug 26, 2025 04:05PM
Aug 25, 2025 04:05PM
Aug 25, 2025 04:05PM
Aug 11, 2025 04:05PM Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 6, 2025 04:05PM

327,801 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All